Literature DB >> 11377680

Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders.

L B Schwartz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377680     DOI： 10.1016/s0145-2126(01)00020-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  17 in total

1.  Formation of active monomers from tetrameric human beta-tryptase.

Authors:  Ignacio Fajardo; Gunnar Pejler
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

Review 2.  Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

Authors:  Cem Akin; Peter Valent; Luis Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

3.  Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.

Authors:  Cem Akin; Darya Soto; Erica Brittain; Adhuna Chhabra; Lawrence B Schwartz; George H Caughey; Dean D Metcalfe
Journal:  Clin Immunol       Date:  2007-04-20       Impact factor: 3.969

4.  Mastocytosis: the great masquerader.

Authors:  James S W Kong; Suzanne Teuber; Rosemary Hallett; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

5.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

6.  Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.

Authors:  Wolfgang R Sperr; Thomas Pfeiffer; Gregor Hoermann; Susanne Herndlhofer; Christian Sillaber; Christine Mannhalter; Michael Kundi; Peter Valent
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 7.  Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Cem Akin
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

8.  Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.

Authors:  I Alvarez-Twose; S Vañó-Galván; L Sánchez-Muñoz; J M Morgado; A Matito; A Torrelo; P Jaén; L B Schwartz; A Orfao; L Escribano
Journal:  Allergy       Date:  2012-03-28       Impact factor: 13.146

Review 9.  Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

Authors:  Juan-Carlos Cardet; Mariana C Castells; Matthew J Hamilton
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 10.  The serum tryptase test: an emerging robust biomarker in clinical hematology.

Authors:  Peter Valent; Wolfgang R Sperr; Karl Sotlar; Andreas Reiter; Cem Akin; Jason Gotlib; Hans-Peter Horny; Michel Arock
Journal:  Expert Rev Hematol       Date:  2014-08-28       Impact factor: 2.929
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.